| Functionally defined therapeutic targets in diffuse intrinsic pontine glioma CS Grasso, Y Tang, N Truffaux, NE Berlow, L Liu, MA Debily, MJ Quist, ... Nature medicine 21 (6), 555-559, 2015 | 679 | 2015 |
| GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas RG Majzner, S Ramakrishna, KW Yeom, S Patel, H Chinnasamy, ... Nature 603 (7903), 934-941, 2022 | 601 | 2022 |
| Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International … LM Hoffman, SEM Veldhuijzen van Zanten, N Colditz, J Baugh, B Chaney, ... Journal of clinical oncology 36 (19), 1963-1972, 2018 | 391 | 2018 |
| The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants KW Pajtler, SC Mack, V Ramaswamy, CA Smith, H Witt, A Smith, ... Acta neuropathologica 133, 5-12, 2017 | 342 | 2017 |
| Diffuse intrinsic pontine glioma: poised for progress KE Warren Frontiers in oncology 2, 205, 2012 | 339 | 2012 |
| Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma H Nikbakht, E Panditharatna, LG Mikael, R Li, T Gayden, M Osmond, ... Nature communications 7 (1), 11185, 2016 | 258 | 2016 |
| Beyond the blood: brain barrier: the importance of central nervous system (CNS) pharmacokinetics for the treatment of CNS tumors, including diffuse intrinsic pontine glioma KE Warren Frontiers in oncology 8, 239, 2018 | 217 | 2018 |
| Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening GL Lin, KM Wilson, M Ceribelli, BZ Stanton, PJ Woo, S Kreimer, EY Qin, ... Science translational medicine 11 (519), eaaw0064, 2019 | 186 | 2019 |
| Pediatric low-grade gliomas: implications of the biologic era RJ Packer, S Pfister, E Bouffet, R Avery, P Bandopadhayay, M Bornhorst, ... Neuro-oncology 19 (6), 750-761, 2017 | 180 | 2017 |
| Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy E Panditharatna, LB Kilburn, MS Aboian, M Kambhampati, ... Clinical Cancer Research 24 (23), 5850-5859, 2018 | 171 | 2018 |
| Pediatric low-grade gliomas: next biologically driven steps DTW Jones, MW Kieran, E Bouffet, S Alexandrescu, P Bandopadhayay, ... Neuro-oncology 20 (2), 160-173, 2018 | 169 | 2018 |
| Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group J Fangusaro, O Witt, PH Driever, AK Bag, P de Blank, N Kadom, L Kilburn, ... The lancet oncology 21 (6), e305-e316, 2020 | 158 | 2020 |
| Real-time image-guided direct convective perfusion of intrinsic brainstem lesions RR Lonser, KE Warren, JA Butman, Z Quezado, RA Robison, S Walbridge, ... Journal of neurosurgery 107 (1), 190-197, 2007 | 155 | 2007 |
| Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors KE Warren, N Patronas, AA Aikin, PS Albert, FM Balis Journal of the National Cancer Institute 93 (18), 1401-1405, 2001 | 141 | 2001 |
| Contemporary survival endpoints: an international diffuse intrinsic pontine glioma registry study T Cooney, A Lane, U Bartels, E Bouffet, S Goldman, SES Leary, ... Neuro-oncology 19 (9), 1279-1280, 2017 | 138 | 2017 |
| Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group K Warren, R Jakacki, B Widemann, A Aikin, M Libucha, R Packer, ... Cancer chemotherapy and pharmacology 58, 343-347, 2006 | 137 | 2006 |
| Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells A Nellan, C Rota, R Majzner, CM Lester-McCully, AM Griesinger, ... Journal for immunotherapy of cancer 6, 1-14, 2018 | 132 | 2018 |
| Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors KE Warren, JA Frank, JL Black, RS Hill, JH Duyn, AA Aikin, BK Lewis, ... Journal of clinical oncology 18 (5), 1020-1020, 2000 | 125 | 2000 |
| Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee KE Warren, G Vezina, TY Poussaint, M Warmuth-Metz, MC Chamberlain, ... Neuro-oncology 20 (1), 13-23, 2018 | 124 | 2018 |
| Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group C Erker, B Tamrazi, TY Poussaint, S Mueller, D Mata-Mbemba, ... The Lancet Oncology 21 (6), e317-e329, 2020 | 114 | 2020 |
